Issels Integrative Immuno-Oncology June 18, 2015  

Can a New Trial Crack Open the Secret Weak Spot of Cancer Tumors?

Dear Friend,

At Issels® we are always looking for ways to improve outcomes for patients whose cancer has resisted standard therapies. One recent development to watch is tumor profiling. These specialized tests analyze the genetic makeup of a tumor and may be the key for doctors to determine if another, less obvious treatment option might help.

A few recent trials have studied the results of alternative drugs that were assigned based on the results of tumor profile tests. So far, the results are very encouraging for people whose cancer has resisted initial chemotherapy or other standard treatment.

Here's how tumor profiling can unveil the mystery of why a cancer medicine has failed:

• The genetic testing looks for mutations present in the tumor cells.

• Mutations are often found that have more in common with an unrelated form of cancer; for example, a colon cancer tumor could have a mutation common in breast cancer.

• Doctors then provide treatment on a trial basis to see if the patient's condition can be improved by a drug known to defeat the other form of cancer.

The trials have examined results in patients who had already tried other treatment options. In many cases, the metastatic cancer stopped growing or even shrank.

One trial saw positive results in 40% of its 25 patient test group. Another trial found improvement in all 6 patients who received alternative therapies based on tumor profiling.

Seen as part of a trend toward individualized cancer treatments, these new advances place a focus on treating the patient’s disease at the genetic and cellular levels after standard therapies have failed.

To find out more about gene-targeted therapies and cell therapies, please contact us at Issels® Integrative Immuno-Oncology.

Too far to travel?

Read more interesting articles on the "Issels Integrative Immuno-Oncology" news/blog posted every Monday, Wednesday, and Friday. Check It Out Now »

Brain Cancer Immunotherapy Boosted by Tetanus Vaccine

Cancer vaccines train the body's immune system to target and kill cancer cells, often requiring a boost to the patient's immune power. A recent study has found a surprising teammate for brain cancer vaccines: the tetanus shot. Find out more about this interesting study.

Get the Full Story!

The Realities of Living with Stage 4 Breast Cancer

Breast cancer becomes metastatic when it travels through the blood to create tumors in the lungs, liver and other parts of the body. Between 20 and 30 percent of women who are diagnosed with early stage breast cancer will develop MBC, which is treatable but not curable. Find out how these women are banding together to support each other in their journey with cancer.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys. Listen to Godine Weiss' story and how she came to Issels® for treatment.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us